BE847740A - Pyrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant - Google Patents

Pyrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant

Info

Publication number
BE847740A
BE847740A BE171874A BE171874A BE847740A BE 847740 A BE847740 A BE 847740A BE 171874 A BE171874 A BE 171874A BE 171874 A BE171874 A BE 171874A BE 847740 A BE847740 A BE 847740A
Authority
BE
Belgium
Prior art keywords
pyrolidone
creatinine
carboxylate
pharmaceutical compositions
preparation process
Prior art date
Application number
BE171874A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE847740A publication Critical patent/BE847740A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
BE171874A 1975-10-29 1976-10-28 Pyrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant BE847740A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU73680A LU73680A1 (fr) 1975-10-29 1975-10-29

Publications (1)

Publication Number Publication Date
BE847740A true BE847740A (fr) 1977-04-28

Family

ID=19728093

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171874A BE847740A (fr) 1975-10-29 1976-10-28 Pyrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant

Country Status (7)

Country Link
US (1) US4089967A (fr)
JP (1) JPS6021147B2 (fr)
BE (1) BE847740A (fr)
DE (1) DE2648830C3 (fr)
FR (1) FR2329273A1 (fr)
GB (1) GB1511196A (fr)
LU (1) LU73680A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78842A0 (en) * 1985-05-22 1986-09-30 Serono Otc Sa Piperidino-pyridine derivatives and pharmaceutical and cosmetic compositions containing them
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US10645967B2 (en) 2017-08-08 2020-05-12 The Clorox Company Shelf-stable acidified aerated food emulsion

Also Published As

Publication number Publication date
US4089967A (en) 1978-05-16
LU73680A1 (fr) 1977-05-31
JPS6021147B2 (ja) 1985-05-25
FR2329273B1 (fr) 1978-11-17
GB1511196A (en) 1978-05-17
DE2648830C3 (de) 1981-01-29
FR2329273A1 (fr) 1977-05-27
JPS5254016A (en) 1977-05-02
DE2648830A1 (de) 1977-05-05
DE2648830B2 (de) 1980-05-14

Similar Documents

Publication Publication Date Title
BE847742A (fr) Nouvelles imidazolidines, procede de preparation et compositions pharmaceutiques
FR2338271A1 (fr) Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
BE813166A (fr) Alliage mere aluminium-titane-bore et son procede de preparation
FR2511357B1 (fr) Cis-platine microcristallin, son procede de preparation et composition pharmaceutique le contenant
BE824509A (fr) Procede de preparation de compositions pharmaceutiques contenant du bismuth
BE849810A (fr) Nouvelles pyrimidones, procede pour les preparation et compositions pharmaceutiques les contenant
BE828686A (fr) Nouvel acide penicillanique, son procede de preparation et medicament le contenant
BE841121A (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
FR2303554A1 (fr) Nouvelle composition pharmaceutique contenant des ions cuivre et son procede de preparation
FR2326202A2 (fr) L-norleucine-13 motiline. procede pour sa preparation et composition la contenant
FR2299026A1 (fr) Zhiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant
FR2328481A1 (fr) Composition antimicrobienne, procede pour sa preparation et application
BE825458A (fr) Nouveaux derives de piperidine, leur procede de preparation et compositions pharmaceutiques les contenant
BE847740A (fr) Pyrolidone carboxylate de creatinine, son procede de preparation et compositions pharmaceutiques le contenant
BE803474A (fr) Nouvelles 2-alkylamino-dihydropyridines, leur procede de preparation et compositions pharmaceutiques les contenant
BE824658A (fr) Nouveaux acides carboxyliques, procede de preparation et compositions pharmaceutiques
BE827444A (fr) Nouveaux derives de la thyronamine, procede de preparation et compositions pharmaceutiques
BE843115A (fr) Compositions pharmaceutiques contenant de la debrycine heterocolloidale et leur procede de preparation
FR2317298A1 (fr) Nouvelles lactones et leur procede de preparation
BE848909A (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
PT65151A (fr) Procede pour la preparation de nouvelles solutions pharmaceutiques stables
FR2274291A1 (fr) Nouvelles compositions pharmaceutiques et procede pour leur preparation
BE835744A (fr) Derives de 5,7-dihydroxytetraisoquinoline, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives
BE833489A (fr) Nouveaux derives steroides, procede de preparation et compositions pharmaceutiques
BE847290A (fr) Compositions medicamenteuses anti-androgenes, nouvelles oxadiazines, procede de preparation et application

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BOCHER DOMINIQUE

Effective date: 19911031